UBS Group’s ETRACS Monthly Pay 2x Leveraged US High Dividend Low Volatility ETN Series B due Oct 21 2049 HDLB Stock Holding History

UBS Group’s Portfolio HDLB Stock Details HDLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19	Closed	-$286	–	10776
2025 Q4	$286	Buy	19 +9	+90%	+$139	﹤0.01%	10059
2025 Q3	$166	Buy	+10	New	+$162	﹤0.01%	9848
2024 Q2	–	Sell	-133	Closed	-$1.65K	–	9744
2024 Q1	$1.65K	Buy	+133	New	+$1.53K	﹤0.01%	8089
2023 Q1	–	Sell	-899	Closed	-$12.3K	–	9901
2022 Q4	$12.3K	Buy	899 +2	+0.2%	+$27	﹤0.01%	8297
2022 Q3	$10K	Sell	897 -453	-34%	-$6.78K	﹤0.01%	8425
2022 Q2	$21K	Buy	+1,350	New	+$22.9K	﹤0.01%	6808

UBS Group's HDLB Position: Q1 2026 in Review

UBS Group sold out of ETRACS Monthly Pay 2x Leveraged US High Dividend Low Volatility ETN Series B due Oct 21 2049 (HDLB) in Q1 2026, closing a stake of 19 shares — an estimated $286 sold.

UBS Group first reported a position in HDLB in Q2 2022 and held it in 6 quarters. The position peaked at $21K in Q2 2022. 0 funds tracked by Wall St. Rank hold HDLB as of Q1 2026.

UBS Group reported no remaining ETRACS Monthly Pay 2x Leveraged US High Dividend Low Volatility ETN Series B due Oct 21 2049 position as of Q1 2026 after selling out during the quarter.
UBS Group sold 19 ETRACS Monthly Pay 2x Leveraged US High Dividend Low Volatility ETN Series B due Oct 21 2049 shares in Q1 2026, an estimated $286.
UBS Group first reported a position in ETRACS Monthly Pay 2x Leveraged US High Dividend Low Volatility ETN Series B due Oct 21 2049 in Q2 2022 and held it in 6 quarters.
UBS Group's ETRACS Monthly Pay 2x Leveraged US High Dividend Low Volatility ETN Series B due Oct 21 2049 position peaked at $21K in Q2 2022.
0 funds tracked by Wall St. Rank held ETRACS Monthly Pay 2x Leveraged US High Dividend Low Volatility ETN Series B due Oct 21 2049 as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.